News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
Endogena Therapeutics Receives FDA Authorization for Innovative Treatment Targeting AMD
Wednesday, October 25, 2023Endogena Therapeutics Inc a pioneering biotechnology company dedicated to advancing regenerative medicine is excited to announce a significant achievement with the potential to transform lives The US Food and Drug Administration
The FDA Grants Approval for a Novel Therapy Targeting Rare Blood Cancers Known as Myelodysplastic Syndromes
Wednesday, October 25, 2023Today the US Food and Drug Administration has granted its approval to Tibsovo for the treatment of adult patients with relapsed or refractory RR myelodysplastic syndromes who carry an isocitrate dehydrogenase
Genialis and Cancer Research Horizons Collaborate to Develop AI-Enhanced Patient Classification Tools for Cancer Research
Tuesday, October 24, 2023Genialis a company specializing in RNAbased biomarkers has announced a collaborative datasharing initiative with Cancer Research Horizons the innovation division of Cancer Research UK
Alaya.bio Expands Its in Vivo CAR-T Immunotherapy Platform by Acquiring Vital Assets From Ixaka France
Saturday, October 21, 2023Alayabio a biotechnology company specializing in in vivo gene delivery has recently completed the acquisition of all assets previously held by Ixaka France Ixaka was a preclinicalstage immunotherapy biotech firm focused on in vivo CAR Tcell therapy
GeNeuro and Verily Collaborate to Progress Long-COVID Research
Friday, October 20, 2023GeNeuro a biopharmaceutical company listed on Euronext Paris under the symbol GNRO has announced a strategic collaboration with Verily a precision health technology company within Alphabet The aim of this partnership is to investigate biomarkers asso...
ERS Genomics Limited and Syngene International Successfully Conclude Licensing Agreement
Thursday, October 19, 2023ERS Genomics cofounded by Dr Emmanuelle Charpentier who was awarded the Nobel Prize in Chemistry in for her pioneering work in the field of CRISPRCas provides access
Stuart Therapeutics Enters into Exclusive Worldwide Licensing Agreement with Glaukos Corporation
Thursday, October 19, 2023Stuart Therapeutics Inc has announced a licensing agreement with Glaukos Corporation granting Glaukos exclusive global rights to develop and commercialize Stuarts proprietary drug candidate ST
Avanzanite Bioscience Expands Collaboration With Advicenne to Include Additional European Nations
Wednesday, October 18, 2023Avanzanite Bioscience BV has announced an expansion of its commercial partnership with Advicenne a specialty pharmaceutical company based in Paris for the distribution of Sibnayal
Cimeio Therapeutics and the University of Pennsylvania Announce Collaboration for Preclinical Studies on CD45 Universal CAR T Cell Therapy in Blood and Bone Marrow Cancers
Tuesday, October 17, 2023Cimeio Therapeutics has recently announced a new preclinical research partnership with Dr Saar Gill an associate professor of medicine with both MD and PhD qualifications working at the Perelman School of Medicine
SOTIO Expands ADC Pipeline Through Licensing Agreement With Synaffix
Monday, October 16, 2023Synaffix BV a company now part of Lonza focuses on advancing its clinicalstage platform technology for the development of antibodydrug conjugates ADCs with a strong therapeutic index They have entered into a licensing agreement
